Chemoembolization, Therapeutic

"Chemoembolization, Therapeutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Administration of antineoplastic agents together with an embolizing vehicle. This allows slow release of the agent as well as obstruction of the blood supply to the neoplasm.

Descriptor ID	D016461
MeSH Number(s)	E02.520.360.150 E02.926.500.150
Concept/Terms	Chemoembolization, Therapeutic Chemoembolization, Therapeutic Therapeutic Chemoembolization Chemoembolizations, Therapeutic Therapeutic Chemoembolizations

Below are MeSH descriptors whose meaning is more general than "Chemoembolization, Therapeutic".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Hemostatic Techniques [E02.520]
Embolization, Therapeutic [E02.520.360]
Chemoembolization, Therapeutic [E02.520.360.150]
Therapeutic Occlusion [E02.926]
Embolization, Therapeutic [E02.926.500]
Chemoembolization, Therapeutic [E02.926.500.150]

Below are MeSH descriptors whose meaning is related to "Chemoembolization, Therapeutic".

Below are MeSH descriptors whose meaning is more specific than "Chemoembolization, Therapeutic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Chemoembolization, Therapeutic" by people in this website by year, and whether "Chemoembolization, Therapeutic" was a major or minor topic of these publications.

Bar chart showing 44 publications over 20 distinct years, with a maximum of 5 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2005	2	0	2
2006	2	2	4
2007	1	0	1
2008	4	1	5
2009	2	0	2
2010	2	0	2
2011	0	2	2
2012	2	0	2
2013	2	0	2
2015	3	0	3
2016	1	0	1
2017	1	1	2
2018	2	0	2
2019	2	1	3
2020	2	0	2
2021	1	0	1
2022	1	0	1
2023	4	0	4
2024	2	0	2

Below are the most recent publications written about "Chemoembolization, Therapeutic" by people in Profiles.

Asano K, Kageyama K, Yamamoto A, Jogo A, Nakano M, Murai K, Yukawa-Muto Y, Odagiri N, Kotani K, Kozuka R, Kawamura E, Fujii H, Uchida-Kobayashi S, Enomoto M, Kawada N, Miki Y. Predictors of Immediate Deterioration of the Child-Pugh Classification From A to B After Transcatheter Arterial Chemo-Embolization for Treatment-Naive Hepatocellular Carcinoma. Cancer Med. 2024 Nov; 13(21):e70367.

View in: PubMed
Kuon Yeng Escalante CM, Siu Xiao T, Nagaraj RU, Savsani E, Mohammed A, Li J, Lyshchik A, Liu JB, Wessner CE, Tahmasebi A, Soulen MC, Kono Y, Eisenbrey JR. Evaluation of the Contrast-Enhanced Ultrasound Nonradiation Treatment Response Assessment LI-RADS v2024 Using Data From a Multi-Center Transarterial Chemoembolization Study. Acad Radiol. 2024 12; 31(12):5078-5086.

View in: PubMed
Savsani E, Shaw CM, Forsberg F, Wessner CE, Lyshchik A, O'Kane P, Liu JB, Balasubramanya R, Roth CG, Naringrekar H, Keith SW, Tan A, Anton K, Bradigan K, Civan J, Schultz S, Shamimi-Noori S, Hunt S, Soulen MC, Mattrey RF, Kono Y, Eisenbrey JR. Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial. Radiology. 2023 10; 309(1):e230727.

View in: PubMed
Hund HC, Du L, Matsuoka L, Sze DY, Kennedy AS, Golzarian J, Gandhi RT, Collins ZS, Brown DB. Effect of Previous Transarterial Chemoembolization on Survival and Toxicity after Yttrium-90 Transarterial Radioembolization of Hepatocellular Carcinoma in the Radiation-Emitting SIR-Spheres in Nonresectable Liver Tumor Registry. J Vasc Interv Radiol. 2023 12; 34(12):2147-2154.e2.

View in: PubMed
Brown KG, Li J, Margolis R, Trinh B, Eisenbrey JR, Hoyt K. Assessment of Transarterial Chemoembolization Using Super-resolution Ultrasound Imaging and a Rat Model of Hepatocellular Carcinoma. Ultrasound Med Biol. 2023 05; 49(5):1318-1326.

View in: PubMed
Lee P, Makkena A, Tantawi M, Velasquez-Botero F, Eisenbrey JR, Shaw CM. Microwave ablation as a primary versus secondary treatment for hepatocellular carcinoma Diagn Interv Radiol. 2023 03 29; 29(2):359-366.

View in: PubMed
Hund HC, Frantz SK, Wu H, Adeniran OR, Wong TY, Borgmann AJ, Matsuoka L, Geevarghese S, Alexopoulos S, Shingina A, Meranze SG, Baker JC, Garbett S, Brown DB. Six-Year Evaluation of Same-Day Discharge following Conventional Transarterial Chemoembolization of Hepatocellular Carcinoma. J Vasc Interv Radiol. 2023 03; 34(3):378-385.

View in: PubMed
Hai Y, Savsani E, Chong W, Eisenbrey J, Lyshchik A. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdom Radiol (NY). 2021 11; 46(11):5162-5179.

View in: PubMed
Wessner CE, Shaw CM, Stanczak M, Forsberg F, Lyshchik A, Tan A, Eisenbrey JR. Contrast-enhanced Ultrasound Identifies Patent Feeding Vessels in Transarterial Chemoembolization Patients With Residual Tumor Vascularity. Ultrasound Q. 2020 Sep; 36(3):218-223.

View in: PubMed
Oezdemir I, Wessner CE, Shaw C, Eisenbrey JR, Hoyt K. Tumor Vascular Networks Depicted in Contrast-Enhanced Ultrasound Images as a Predictor for Transarterial Chemoembolization Treatment Response. Ultrasound Med Biol. 2020 09; 46(9):2276-2286.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement